Candel Therapeutics (CADL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Voting matters and shareholder proposals
Election of four Class II directors: Edward J. Benz, Jr., Paul B. Manning, Maha Radhakrishnan, and Paul Peter Tak, with board recommending a vote in favor.
Ratification of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, recommended by the board.
Additional business may be addressed if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends all four nominees for Class II director positions.
Audit committee and external auditor matters
Proposal to ratify KPMG LLP as the external auditor for the 2026 fiscal year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Candel Therapeutics
- Aglatimagene with radiotherapy improves survival and reduces recurrence in prostate cancer.CADL
Study result15 May 2026 - Aglatimagene and linoserpaturev show strong efficacy and safety across multiple cancer indications.CADL
Corporate presentation14 May 2026 - Lead programs show strong efficacy and safety across major cancers, with broad market potential.CADL
Corporate presentation14 May 2026 - Net loss of $8.9M in Q1 2026; BLA submission and launch prep for aglatimagene advance.CADL
Q1 202614 May 2026 - Virtual meeting to elect directors, ratify auditor, and review governance and compensation.CADL
Proxy filing29 Apr 2026 - Aglatimagene and linoserpaturev show strong efficacy and safety across multiple cancer types.CADL
Corporate presentation16 Apr 2026 - Lead programs show strong efficacy and safety in major cancers, with broad commercial potential.CADL
Corporate presentation23 Mar 2026 - Pivotal trials and BLA submission planned for 2026, with strong financial runway into 2028.CADL
Q4 202512 Mar 2026 - Pivotal phase III success in prostate cancer and promising glioma data drive 2024 milestones.CADL
TD Cowen 46th Annual Health Care Conference3 Mar 2026